Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & workings
1.3 Forecast calculations
1.4 Data Sources
1.4.1 Primary
1.4.2 Secondary
1.4.2.1 Paid sources
1.4.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Global smart inhalers market 3600 synopsis, 2018 – 2032
2.2 Regional trends
2.3 Product trends
2.4 Disease indication trends
2.5 Distribution channel trends
Chapter 3 Smart Inhalers Industry Insights
3.1 COVID- 19 impact analysis
3.2 Industry ecosystem analysis
3.3 Technology landscape
3.4 Regulatory landscape
3.5 Industry impact forces
3.5.1 Growth drivers
3.5.1.1 Growing prevalence of respiratory diseases across the globe
3.5.1.2 Technological advancements in smart inhalers
3.5.1.3 Increasing number of partnership agreements between pharma and software companies
3.5.1.4 Increased medical adherence
3.5.2 Industry pitfalls & challenges
3.5.2.1 Dearth of awareness in developing countries
3.5.2.2 Significant security risks and privacy issues
3.6 Growth potential analysis
3.6.1 By product
3.6.2 By disease indication
3.6.3 By distribution channel
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.1.1 Adherium
4.1.2 GlaxoSmithKline Plc
4.1.3 Novartis AG
4.2 Competitive analysis of major market players, 2022
4.3 Competitive positioning matrix, 2022
4.4 Strategic outlook matrix, 2022
Chapter 5 Smart Inhalers Market Size and Forecast, By Product, 2018-2032 (USD Million)
5.1 Key trends, by product
5.2 Dry powder inhaler (DPI)-based smart inhalers
5.3 Metered dose inhaler (MDI)-based smart inhalers
Chapter 6 Smart Inhalers Market Size and Forecast, By Disease Indication, 2018-2032 (USD Million)
6.1 Key trends, by disease indication
6.2 Asthma
6.3 Chronic obstructive pulmonary diseases
Chapter 7 Smart Inhalers Market Size and Forecast, By Distribution Channel, 2018-2032 (USD Million)
7.1 Key trends, by distribution channel
7.2 Hospital pharmacies
7.3 Retail pharmacies
7.4 E-commerce
Chapter 8 Smart Inhalers Market Size and Forecast, By Region, 2018-2032 (USD Million)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Rest of Latin America
8.6 Middle East & Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 Turkey
8.6.4 Rest of Middle East & Africa
Chapter 9 Company Profiles
9.1 Adherium
9.2 Propeller Health
9.3 Nemera
9.4 GlaxoSmithKline Plc.
9.5 Novartis AG
9.6 Aptar Group Inc.
9.7 AstraZeneca Plc
9.8 Findair Sp. Z.o.o.
9.9 BioCorp
9.10 Zeolr Technologies Pvt Ltd.
9.11 Vectura Group Plc.
9.12 Teva Pharmaceutical Industries Ltd.
9.13 Boehringer Ingelheim International GmbH
